7Hsu CY,Lin HC,Huang YH,et al.Comparison of the model for end-stage liver disease-stage liver disease (MELD),MELD-Na and MELDNa for outcome prediction in patients with acute decompensatod hepatitis[J].Dig Liver Dis, 2010,42 (2) : 137-149.
2KAMATH PS,WIESNER RH,MALINCHOC M,et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology,2001,33(2):464-470.
3GIANNINI E,BOTTA F,TESTA E,et al.The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis[J].Am J Gastroenterol,2002,97(11):2855-2860.
4HABIB A,MIHAS AA,ABOU-ASSI SG,et al.High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics[J].Clin Gastroenterol Hepatol,2005,3(3):286-291.
5RUF AE,KREMERS WK,CHAVEZ LL,et al.Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone[J].Liver Transpl,2005,11(3):336-343.
6HONG MH.Design Measurement Evaluation (the second edition)[M].Guangzhou:Zhong Shan University Publishing Company,2002:59.Chinese
7ROBERT A,CHAZOUILLERES O.Prothrombin time in liver failure:time,ratio,activity percentage,or international normalized ratio[J].Hepatology,1996,24(6):1392-1394.
8GHOBRIAL RM,GORNBEIN J,STEADMAN R,et al.Pretransplant model to Predict posttransplant survival in liver transplant patients[J].Ann Surg,2002,236(3):315-323.
9HEUMAN DM,ABOU-ASSI SG,HABIB A,et al.Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death[J].Hepatology,2004,40(4):802-810.
10SAAB S,IBRAHIM AB,SHPANER A,et al.MELD fails to measure quality of life in liver transplant candidates[J].Liver Transpl,2005,11(2):218-223.
